Literature DB >> 7954768

Intravascular ultrasound imaging after excimer laser angioplasty.

J Honye1, D J Mahon, S Nakamura, J Wallis, A al-Zarka, S Saito, M Berns, J M Tobis.   

Abstract

To help elucidate the mechanism of excimer laser coronary angioplasty (ELCA), intravascular ultrasound (IVUS) imaging was performed in 19 of 29 patients who were treated with ELCA. The results were compared with a non-randomized control group of 18 patients who had IVUS studies both before and after PTCA alone. After ELCA alone, lumen diameter (1.9 x 1.7 mm) and lumen cross-sectional area (CSA) (2.9 mm2) by IVUS were not significantly different from baseline values in the patients before PTCA alone (2.1 x 1.8 mm, 3.2 mm2). After balloon dilatation in the laser treated group, lumen diameter (2.5 x 2.1 mm) and lumen CSA (4.9 mm2) were significantly greater than those post ELCA alone. However, there was no difference in lumen CSA or atheroma CSA in the group treated with excimer laser plus balloon dilatation vs. these measurements in the group treated with PTCA alone. ELCA does not ablate a large amount of atheroma (9% reduction) but creates a pathway to permit easier passage of a PTCA balloon. These quantitative and morphologic results may help explain why the restenosis rate with ELCA is similar to PTCA alone.

Entities:  

Mesh:

Year:  1994        PMID: 7954768     DOI: 10.1002/ccd.1810320304

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  2 in total

Review 1.  [Laser angioplasty and recanalization].

Authors:  M Haude; D Welge; L Koch; T Roth; J Ge; D Baumgart; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

2.  Laser Vaporization of Intracoronary Thrombus and Identifying Plaque Morphology in ST-Segment Elevation Myocardial Infarction as Assessed by Optical Coherence Tomography.

Authors:  Yuki Yamanaka; Yoshihisa Shimada; Daisuke Tonomura; Kazunori Terashita; Tatsuya Suzuki; Kentaro Yano; Satoshi Nishiura; Masataka Yoshida; Takao Tsuchida; Hitoshi Fukumoto
Journal:  J Interv Cardiol       Date:  2021-07-28       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.